Sonova Holding AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CH0012549785
CHF
200.00
-1.1 (-0.55%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

131.81 k

Shareholding (Dec 2023)

FII

0.04%

Held by 3 FIIs

DII

99.96%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Flat results in Mar 25

  • INTEREST(HY) At CHF 24.2 MM has Grown at 39.88%
  • OPERATING CASH FLOW(Y) Lowest at CHF 1,503.4 MM
  • ROCE(HY) Lowest at 21.06%
2

With ROE of 21.92%, it has a Very Expensive valuation with a 4.90 Price to Book Value

3

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CHF 12,021 Million ()

stock-summary
P/E

22.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

223.86%

stock-summary
Debt Equity

0.49

stock-summary
Return on Equity

23.75%

stock-summary
Price to Book

4.95

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-15.93%
0%
-15.93%
6 Months
-22.3%
0%
-22.3%
1 Year
-31.58%
0%
-31.58%
2 Years
-22.33%
0%
-22.33%
3 Years
-17.39%
0%
-17.39%
4 Years
-41.84%
0%
-41.84%
5 Years
-9.87%
0%
-9.87%

Sonova Holding AG for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
8.49%
EBIT Growth (5y)
10.45%
EBIT to Interest (avg)
17.82
Debt to EBITDA (avg)
0.78
Net Debt to Equity (avg)
0.33
Sales to Capital Employed (avg)
0.89
Tax Ratio
16.24%
Dividend Payout Ratio
48.52%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
21.77%
ROE (avg)
24.87%
Valuation key factors
Factor
Value
P/E Ratio
22
Industry P/E
Price to Book Value
4.90
EV to EBIT
18.95
EV to EBITDA
14.17
EV to Capital Employed
3.92
EV to Sales
3.61
PEG Ratio
NA
Dividend Yield
206.08%
ROCE (Latest)
20.70%
ROE (Latest)
21.92%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2023stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 3 Foreign Institutions (0.04%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Sonova Holding AG"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2023 is 11.13% vs 29.29% in Mar 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2023 is -0.80% vs 13.38% in Mar 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'23",
        "Mar'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,738.40",
          "val2": "3,363.90",
          "chgp": "11.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,001.50",
          "val2": "996.20",
          "chgp": "0.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "23.10",
          "val2": "34.50",
          "chgp": "-33.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-30.20",
          "val2": "-14.90",
          "chgp": "-102.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "658.30",
          "val2": "663.60",
          "chgp": "-0.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "203.80%",
          "val2": "233.40%",
          "chgp": "-2.96%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Mar'23stock-summary
Mar'23
Mar'22
Change(%)
Net Sales
3,738.40
3,363.90
11.13%
Operating Profit (PBDIT) excl Other Income
1,001.50
996.20
0.53%
Interest
23.10
34.50
-33.04%
Exceptional Items
-30.20
-14.90
-102.68%
Consolidate Net Profit
658.30
663.60
-0.80%
Operating Profit Margin (Excl OI)
203.80%
233.40%
-2.96%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2023 is 11.13% vs 29.29% in Mar 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2023 is -0.80% vs 13.38% in Mar 2022

stock-summaryCompany CV
About Sonova Holding AG stock-summary
stock-summary
Sonova Holding AG
Pharmaceuticals & Biotechnology
Sonova Holding AG is a Switzerland-based company operating in the healthcare sector. The Company, along with its subsidiaries, designs, develops, manufactures, distributes and services hearing systems for adults and children with hearing impairment. The Company is active in two operating segments: the Hearing instruments segment includes the companies that are active in the design, development, manufacture, distribution and service of hearing instruments and related products, and the Cochlear implants segment includes the companies that are active in the design, development, manufacture, distribution and service of hearing implants and related products. It operates worldwide and distributes its products in over 90 countries through its own distribution network and through independent distributors. Sonova Holding AG is the holding company of the Sonova Group and operates the wholly owned subsidiaries Comfort Audio GmbH and Hansaton Akustik GmbH.
Company Coordinates stock-summary
Company Details
Laubisruetistrasse 28 , STAEFA None : 8712
stock-summary
Tel: 41 58 928333341 58 9283344
stock-summary
Registrar Details